Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Published
Original News Source
CNBC — Business
Source Website
www.cnbc.com ↗
Content & Media Rights
CNBC — Business
Editorial Publisher
360 NEWS (Independent Media)
360 News
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].

